Strategies that target cancers with FBXW7 loss of function can include the reactivation of FBXW7 expression in tumors with wild-type FBXW7, which may have been inactivated through epigenetic mechanisms, or targeting downstream effectors of FBXW7 inactivation in tumors with gene mutations or deletions [8]. The gene discussed is FBXW7; the disease is cancer.